Claris Lifesciences Ltd.
| BSE: 533288 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE562G01018 |
| BSE 09:19 | 14 Mar | Claris Lifesciences Ltd |
| NSE 05:30 | 01 Jan | Claris Lifesciences Ltd |
| OPEN | 395.10 |
| PREVIOUS CLOSE | 396.05 |
| VOLUME | 1002 |
| 52-Week high | 396.50 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 2,161 |
| Buy Price | 396.05 |
| Buy Qty | 13.00 |
| Sell Price | 396.90 |
| Sell Qty | 100.00 |
Claris Lifesciences Ltd. (CLARISLIFESCIEN) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 878.20 | -3.10 | -0.35 | 13266.48 |
| Cipla | 771.80 | 11.40 | 1.50 | 12659.15 |
| Sun Pharma.Inds. | 531.45 | 10.65 | 2.04 | 12531.93 |
| Dr Reddy's Labs | 4520.55 | 16.35 | 0.36 | 11850.40 |
| Lupin | 1018.85 | 88.45 | 9.51 | 11025.66 |
| Apollo Hospitals | 1707.45 | -20.00 | -1.16 | 8336.66 |
| Alkem Lab | 2931.25 | 24.55 | 0.84 | 6677.08 |
| Cadila Health. | 395.45 | 9.55 | 2.47 | 6347.40 |
| Glenmark Pharma. | 475.40 | 10.85 | 2.34 | 6304.87 |
| Torrent Pharma. | 2839.00 | 42.30 | 1.51 | 6168.44 |
| Divi's Lab. | 3093.00 | -31.25 | -1.00 | 4879.66 |
| Piramal Enterp. | 1431.40 | -34.85 | -2.38 | 4219.19 |
| Alembic Pharma | 1036.75 | -40.80 | -3.79 | 4132.55 |
| Abbott India | 16460.80 | -209.40 | -1.26 | 3678.60 |
| Ipca Labs. | 2013.20 | 23.85 | 1.20 | 3605.66 |
| Glaxosmi. Pharma | 1520.65 | -2.95 | -0.19 | 3224.68 |
| Jubilant Life | 807.70 | 0.25 | 0.03 | 3139.90 |
| Sanofi India | 8325.80 | 139.45 | 1.70 | 3070.60 |
| Laurus Labs | 1009.65 | -20.90 | -2.03 | 2797.34 |
| Nectar Lifesci. | 21.45 | -0.50 | -2.28 | 2784.93 |
Quick Links for Claris Lifesciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
